As of today (2022-07-02), PTC Therapeutics's share price is $41.85.
PTC Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $-5.58. Hence, PTC Therapeutics's Price-to-Free-Cash-Flow Ratio for today is .
The historical rank and industry rank for PTC Therapeutics's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 11 years, PTC Therapeutics's highest Price-to-Free-Cash-Flow Ratio was 2514.21. The lowest was 1776.84. And the median was 2077.89.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -72.70% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -14.20% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was -7.20% per year.
During the past 11 years, PTC Therapeutics's highest 3-Year average Free Cash Flow per Share Growth Rate was 37.40% per year. The lowest was -72.70% per year. And the median was -11.75% per year.
PTC Therapeutics Price-to-Free-Cash-Flow Historical Data
The historical data trend for PTC Therapeutics's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
PTC Therapeutics Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Price-to-Free-Cash-Flow
-
-
-
-
-
PTC Therapeutics Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Price-to-Free-Cash-Flow
-
-
-
-
-
Competitive Comparison
For the Biotechnology subindustry, PTC Therapeutics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PTC Therapeutics Price-to-Free-Cash-Flow Distribution
For the Biotechnology industry and Healthcare sector, PTC Therapeutics's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where PTC Therapeutics's Price-to-Free-Cash-Flow falls into.
PTC Therapeutics's Share Price of today is $41.85.
PTC Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.58.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
PTC Therapeutics Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of PTC Therapeutics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
1.79(4.47%) Volume: 512,546 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:PTCT has been successfully added to your 
